Genelux Statistics
Total Valuation
Genelux has a market cap or net worth of $104.05 million. The enterprise value is $70.74 million.
Important Dates
The last earnings date was Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Genelux has 37.29 million shares outstanding. The number of shares has increased by 27.52% in one year.
| Current Share Class | 37.29M |
| Shares Outstanding | 37.29M |
| Shares Change (YoY) | +27.52% |
| Shares Change (QoQ) | +0.98% |
| Owned by Insiders (%) | 11.08% |
| Owned by Institutions (%) | 14.32% |
| Float | 30.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.53 |
| P/TBV Ratio | 3.49 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.67, with a Debt / Equity ratio of 0.06.
| Current Ratio | 4.67 |
| Quick Ratio | 4.57 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -131.36% and return on invested capital (ROIC) is -79.95%.
| Return on Equity (ROE) | -131.36% |
| Return on Assets (ROA) | -61.65% |
| Return on Invested Capital (ROIC) | -79.95% |
| Return on Capital Employed (ROCE) | -100.32% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.23M |
| Employee Count | 24 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.42% in the last 52 weeks. The beta is -0.36, so Genelux's price volatility has been lower than the market average.
| Beta (5Y) | -0.36 |
| 52-Week Price Change | -27.42% |
| 50-Day Moving Average | 3.02 |
| 200-Day Moving Average | 2.87 |
| Relative Strength Index (RSI) | 50.12 |
| Average Volume (20 Days) | 154,407 |
Short Selling Information
The latest short interest is 2.17 million, so 5.81% of the outstanding shares have been sold short.
| Short Interest | 2.17M |
| Short Previous Month | 2.30M |
| Short % of Shares Out | 5.81% |
| Short % of Float | 7.07% |
| Short Ratio (days to cover) | 11.76 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -31.40M |
| Pretax Income | -25.78M |
| Net Income | -29.51M |
| EBITDA | -31.19M |
| EBIT | -31.40M |
| Earnings Per Share (EPS) | -$0.88 |
Full Income StatementBalance Sheet
The company has $35.10 million in cash and $1.79 million in debt, giving a net cash position of $33.32 million or $0.89 per share.
| Cash & Cash Equivalents | 35.10M |
| Total Debt | 1.79M |
| Net Cash | 33.32M |
| Net Cash Per Share | $0.89 |
| Equity (Book Value) | 29.85M |
| Book Value Per Share | 0.79 |
| Working Capital | 28.26M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$22.31 million and capital expenditures -$381,000, giving a free cash flow of -$22.69 million.
| Operating Cash Flow | -22.31M |
| Capital Expenditures | -381,000 |
| Free Cash Flow | -22.69M |
| FCF Per Share | -$0.61 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |